Proteomic study via a non-gel based approach of meningococcal outer membrane vesicle vaccine obtained from strain CU385: A road map for discovering new antigens
Jeovanis Gil(Lund University), Vladimir Besada, Aniel Sánchez, Olivia Niebla(Centro de Ingeniería Genética y Biotecnología), Ramón Barberá(Finlay Institute), Lázaro Betancourt(Centro de Ingeniería Genética y Biotecnología), Maité Delgado, Rolando Pajón(Moderna Therapeutics (United States)), Luís Herrera(Orlando Health), Darién García(Centro de Ingeniería Genética y Biotecnología), Gerardo Guillén(Hunan City University), Gabrìel Padrón, Concepción Campa, Franklin Sotolongo(Finlay Institute), Gretel Sardiñas, Luis Javier González(Centro de Ingeniería Genética y Biotecnología), Daniel Yero(Universitat Autònoma de Barcelona)
Cited by 26
Related Papers
Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial
|Science|2022|1.2k
Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase
|New England Journal of Medicine|2021|661
Epidermal growth factor in clinical practice – a review of its biological actions, clinical indications and safety implications
|International Wound Journal|2009|167
A novel cancer vaccine composed of human-recombinant epidermal growth factor linked to a carrier protein: Report of a pilot clinical trial
|Annals of Oncology|1998|155
Glucose Toxic Effects on Granulation Tissue Productive Cells: The Diabetics’ Impaired Healing
|BioMed Research International|2012|153